Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8–13 Weeks’ Gestation

Publisher： Karger

E-ISSN： 1421-9964|31|2|87-93

ISSN： 1015-3837

Source： Fetal Diagnosis and Therapy, Vol.31, Iss.2, 2012-01, pp. : 87-93

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maternal Serum Placental Growth Factor (PlGF) Isoforms 1 and 2 at 11-13 Weeks' Gestation in Normal and Pathological Pregnancies

By  

Fetal Diagnosis and Therapy, Vol. 36, Iss. 2, 2014-01 ,pp. : 106-116

Karger

Access to resources Recommend Favorite

Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-05 ,pp. : 240-248

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Factor Isoforms 1 and 2 at 11-13, 20-24 and 30-34 Weeks' Gestation in Late-Onset Pre-Eclampsia and Small for Gestational Age Neonates

By  

Fetal Diagnosis and Therapy, Vol. 35, Iss. 4, 2014-03 ,pp. : 249-257

Karger

Access to resources Recommend Favorite

Temporal Effect of Afro-Caribbean Race on Serum Pregnancy-Associated Plasma Protein-A at 9–13 Weeks’ Gestation in Screening for Aneuploidies

By  

Fetal Diagnosis and Therapy, Vol. 31, Iss. 3, 2012-02 ,pp. : 162-169

Karger

Access to resources Recommend Favorite

Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia

By  

Fetal Diagnosis and Therapy, Vol. 33, Iss. 3, 2013-02 ,pp. : 164-172

Karger

Access to resources Recommend Favorite